ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1004

Reevaluating Citrullination and Peptidylarginine Deiminases in Neutrophil Extracellular Trap-like Structures

Caitlyn L. Holmes1, Daeun Shim2, John Kernien1, Chad J. Johnson1, Jeniel E. Nett3 and Miriam A. Shelef4,5, 1University of Wisconsin - Madison, Madison, WI, 2Medicine, University of Wisconsin - Madison, Madison, WI, 3Medicine and Medical Microbiology and Immunology, University of Wisconsin - Madison, Madison, WI, 4Department of Medicine, Division of Rheumatology, University of Wisconsin - Madison, Madison, WI, 5William S. Middleton Memorial Veterans Hospital, Madison, WI

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Neutrophil Extracellular Traps, PAD and citrullination

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Innate Immunity Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Neutrophil extracellular traps (NETs) are webs of chromatin and proteins extruded from neutrophils during NETosis. NETs are increased and display citrullinated proteins that are targeted by autoantibodies in rheumatoid arthritis. Citrullination, the posttranslational deimination of arginines to citrullines, is catalyzed by the peptidylarginine deiminases (PADs). Thus, NETs and PADs are thought to be important in the pathophysiology of rheumatoid arthritis. However, not all stimuli induce NETs with citrullinated proteins and, further, it has been suggested that different stimuli may induce different types of NET-like structures defined in part by the presence or absence of citrullination. Also, the requirement for PAD2 and PAD4, the main PADs expressed in neutrophils, in the formation of different NET-like structures has not been clearly defined, in part because many studies assess only citrullinated NETs. Here, we determine if specific stimulants induce citrullinated and/or uncitrullinated NET-like structures in humans and mice and if those structures require PAD2 or PAD4.

Methods: Neutrophils were isolated from human peripheral blood or the bone marrow of wild type, PAD4-/-, and PAD2-/- mice and were treated for 4 hours with no stimulant, ionomycin, monosodium urate (MSU) crystals, phorbol myristate acetate (PMA), or Candida albicans. Cells were fixed, stained with 4’6-diamidino-2-phenylindole (DAPI) and an anti-citrulline antibody (F95) and imaged at preset locations at 400x. NET-like structures, defined as highly decondensed DNA, were quantified in a blinded manner. A t-test was used to analyze results with p<0.05 considered significant.

Results: PMA, MSU, and C. albicans were strong activators of NET-like structures in human neutrophils with MSU and C. albicans inducing primarily citrullinated NET-like structures and PMA primarily uncitrullinated. Ionomycin was a weak inducer of NET-like structures, about a third of which were citrullinated. In contrast, ionomycin and C. albicans were strong inducers of NET-like structures in murine neutrophils with ionomycin-induced NETs mostly citrullinated. MSU variably induced NET-like structures and PMA induced very few NET-like structures in mice, which were almost all uncitrullinated. Murine C. albicans- and MSU-induced NET-like structures were a mix of citrullinated and uncitrullinated. PAD4-/- neutrophils generated almost no citrullinated NET-like structures, with similar numbers of uncitrullinated NET-like structures to PAD4+/+ neutrophils. PAD2-/- neutrophils demonstrated no defects in any NET-like structures.

Conclusion: Different stimuli induce varying proportions of citrullinated and uncitrullinated NET-like structures in mice and humans making it difficult to define NET subsets by citrullination status and stimulant. PAD4 is required for the generation of citrullinated NET-like structures only, whereas PAD2 is dispensable for any murine NET-like structure. These findings critically inform the design and interpretation of studies evaluating the role of citrullination, PADs, and NET-like structures in rheumatoid arthritis.


Disclosure: C. L. Holmes, None; D. Shim, None; J. Kernien, None; C. J. Johnson, None; J. E. Nett, None; M. A. Shelef, None.

To cite this abstract in AMA style:

Holmes CL, Shim D, Kernien J, Johnson CJ, Nett JE, Shelef MA. Reevaluating Citrullination and Peptidylarginine Deiminases in Neutrophil Extracellular Trap-like Structures [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/reevaluating-citrullination-and-peptidylarginine-deiminases-in-neutrophil-extracellular-trap-like-structures/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reevaluating-citrullination-and-peptidylarginine-deiminases-in-neutrophil-extracellular-trap-like-structures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology